Compositions for pharmaceutical, veterinary and medical purposes comprised of microbials and/or sugar or polysaccharides for the treatment or prevention of microbiome dysbiosis and/or diseases associated therewith; dietary supplements, nutritional supplements, nutraceuticals for use as a nutritional agent, dietary supplement, food supplements, and microbiome-modulating and/or nutritional beverages and food bars containing microorganisms and/or sugar or polysaccharides for medical therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms and/or sugar or polysaccharides for medical and veterinary use for the treatment or prevention of diseases of the immune system, impaired epithelium or diseases with microbiome dysbiosis; therapeutic medication consumer products, namely skin or mucosal (e.g., mouth, eyes, vagina, rectum/anus, nose, lung) moisturizers, creams, lotions, gels, toners, cleansers, and/or cosmetics, and/or medical diagnostic and prognostic test media in the form of strips, threads, liquids, reagents, solids, or kits, for measuring the microbiome and any markers associated therewith consisting of designed ecologies of microorganisms, combinations of microorganisms, individually selected microorganisms, simple sugars, polysaccharides and combinations of microorganisms and simple sugars and/or polysaccharides; diagnostic kits consisting primarily of microbials, prebiotics, laxatives, colon prep, antibiotics, sample collection kits and/or diagnostic reagents for the detection of microbes, microbial metabolites and inflammatory biomarkers associated with diseases of the immune system, impaired epithelium or diseases with microbiome dysbiosis; diagnostics and tools, namely microbials, prebiotics, laxatives, colon prep, antibiotics, sample collection kits and/or diagnostic reagents for medical purposes for assessing immune status and systemic flares; diagnostics and tools, namely microbials, prebiotics, laxatives, colon prep, antibiotics, sample collection kits and/or diagnostic reagents for medical purposes for determining an appropriate prevention and treatment course for diseases of the immune system, impaired epithelium or diseases with microbiome dysbiosis

Medical devices, apparatus and instruments for acquisition and collection of large-scale genomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data

Scientific, chemical/biochemical research and microbiological research; scientific research in the field of defining and selecting microbial and/or sugar/polysaccharide compositions for research and development of therapeutics, consumer products, diagnostic, prognostic tools and methods consisting of consisting of designed ecologies of microorganisms, combinations of microorganisms, individually selected microorganisms, simple sugars, polysaccharides and combinations of microorganisms and simple sugars and/or polysaccharides; scientific and technological services, in the nature of acquisition, collection, analysis, compilation, and/or electronic storage and distribution of large-scale metagenomic, genomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data for treatment and diagnostic purposes, namely, laboratory research and analysis services and/or diagnostic services; services for the development of computer databases and computer-readable programs and scientific, analytical, and statistical tools for genomic, proteomic, transcriptomic, epigenetic, and metabolomic data, including patient clinical care information and medical research data; health care analytical services, namely scientific study and treatment, prevention, diagnostic and research in the field of health care

Human and veterinary medicine services; medical diagnostic testing, monitoring and reporting services in the field of chemical, biochemical, and molecular diagnostic services, including chemical, immunological, and microbiological diagnostic services